Table 5.

Comparison of monocyte profiles and MPC content in AMI patients with or without in-hospital complications.

Parameters	Complications	No complications	p
	Composite end-point	No composite end-point
% MPC	14.28±2.60	7.31±1.07	0.0053*
MPC concentration	78.33±9.03	46.36±6.39	0.0290*
% MPC with classical monocytes	10.68±1.61	4.48±0.41	0.0002*
% MPC with intermediate monocytes	21.87±1.94	14.15±2.72	0.0358*
% MPC with non-classical monocytes	8.61±0.97	4.47±0.54	0.0151*
MPC concentration with classical monocytes	52.02±6.58	26.85±2.71	0.0025*
MPC concentration with intermediate monocytes	6.80±1.21	7.93±2.73	0.9301
MPC concentration with non-classical monocytes	1.36±0.33	0.74±0.18	0.2344
% AnnexinV+ total events in plasma from all CD41a+ events	43.80±5.72	24.00±4.27	0.3168
% AnnexinV+ platelets in plasma from all CD41a+ platelets	37.42±8.13	1.00±0.18	0.0276*
% AnnexinV+ vesicles in plasma from all CD41a+ vesicles	57.92±3.70	31.41±4.23	0.0446*
	LV aneurism on day 1	No LV aneurism on day 1
% MPC with classical monocytes	9.00±1.26	7.01±2.05	0.0283*
% AnnexinV+ platelets in plasma from all CD41a+ platelets	37.42±8.13	1.00±0.18	0.0276*
% AnnexinV+ vesicles in plasma from all CD41a+ vesicles	57.92±3.70	31.41±4.23	0.0446*
	LV aneurism on day 7	No LV aneurism on day 7
% AnnexinV+ vesicles in plasma from all CD41a+ vesicles	63.93±6.49	32.26±3.31	0.0278*
Concentration of intermediate monocytes	27.59±5.18	48.82±5.50	0.0433*
	Intracoronary thrombosis	No intracoronary thrombosis
Concentration of intermediate monocytes	20.64±6.85	45.43±5.34	0.0433*

Data are presented as means ± SEM.

^*p<0.05 according to Mann-Witney U-test.